LITCHMAN MANUEL MD (President and CEO) purchased 25.1% of their position (165.56K shares) of MUSTANG BIO, INC. on the open market
Open‑market purchase worth $516.6K — a significant purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 3/15/2021ACC: 0001104659-21-035857
DirectorOfficer· President and CEO
Since Nov 2018
+170.56K
Net shares
Net buyer
$530.7K
Total acquired
1
Open market trades
1B · 0S
2
Total transactions
170.56K acquired
Non-Derivative Transactions2
COMMON STOCK
Direct
Shares
+5K
Price / share
$2.83
Trade value
$14.15K
% of position
0.8%
2/26/2021
654.85K→659.85K
COMMON STOCK
Direct
Shares
+165.56K
Price / share
$3.12
Trade value
$516.55K
% of position
25.1%
3/5/2021
659.85K→825.41K
Total
Net shares
+170.56K
Net value
$530.70K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| COMMON STOCK Direct | 2/26/2021 | A · Award | +5K | $2.83 | $14.15K | 0.8% | 654.85K | 659.85K |
| COMMON STOCK Direct | 3/5/2021 | P · Purchase | +165.56K | $3.12 | $516.55K | 25.1% | 659.85K | 825.41K |
| Total | +170.56K | $530.70K | ||||||
Derivative Transactions0
No derivative transactions reported